Letter to the editor
The role of ERCC2 polymorphisms in breast cancer risk

https://doi.org/10.1016/j.cancergencyto.2006.04.017Get rights and content

Section snippets

Acknowledgments

We wish to thank Luísa Manso Oliveira, Lylliane Luz, and Maria do Carmo Alves for technical assistance. The projects from Fundação Calouste Gulbenkian (69405) and Fundação da Ciência e Tecnologia (FCT) (POCTI/BIO/38922/2000 and POCTI/QUI/57110/2004) support our current research. The PhD grants SFRH/BD/2931/2000 and SFRH/BD/17828/2004 from FCT are also acknowledged.

References (14)

  • L. Zhang et al.

    Single nucleotide polymorphisms for DNA repair genes in breast cancer patients

    Clin Chim Acta

    (2005)
  • K. Hemminki et al.

    XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ

    Carcinogenesis

    (2001)
  • C. Justenhoven et al.

    ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population

    Cancer Epidemiol Biomarkers Prev

    (2004)
  • B. Kuschel et al.

    Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk

    Cancer Epidemiol Biomarkers Prev

    (2005)
  • S.A. Lee et al.

    Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer

    Exp Mol Med

    (2005)
  • S.N. Silva et al.

    Association of polymorphisms in ERCC2 gene with non-familial thyroid cancer risk

    Cancer Epidemiol Biomarkers Prev

    (2005)
  • G.B. Castro et al.

    The absence of death by breast cancer among indigenous women living in Mato Grosso, Brazil 2000: protection or undernotification?

    J Womens Cancer

    (2002)
There are more references available in the full text version of this article.
View full text